omeprazole has been researched along with Idiopathic Parkinson Disease in 2 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bjarnason, IT | 2 |
| Charlett, A | 1 |
| Dobbs, RJ | 1 |
| Dobbs, SM | 1 |
| Ibrahim, MA | 1 |
| Kerwin, RW | 1 |
| Mahler, RF | 1 |
| Oxlade, NL | 1 |
| Peterson, DW | 1 |
| Plant, JM | 1 |
| Price, AB | 1 |
| Weller, C | 1 |
| Pierantozzi, M | 1 |
| Pietroiusti, A | 1 |
| Galante, A | 1 |
| Sancesario, G | 1 |
| Lunardi, G | 1 |
| Fedele, E | 1 |
| Giacomini, P | 1 |
| Stanzione, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Helicobacter Pylori Eradication and Motor Fluctuations in Parkinson's Disease[NCT00664209] | Phase 3 | 64 participants (Actual) | Interventional | 2008-01-31 | Terminated (stopped due to Prevalence of H Pylori in the study population was much lower than anticipated) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Side effects profile (NCT00664209)
Timeframe: 2 months
| Intervention | participants (Number) |
|---|---|
| Active | 0 |
2 trials available for omeprazole and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 2: response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomized, double-b
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Double-Blind | 2005 |
Helicobacter pylori-induced reduction of acute levodopa absorption in Parkinson's disease patients.
Topics: Administration, Oral; Aged; Analysis of Variance; Anti-Bacterial Agents; Anti-Ulcer Agents; Area Und | 2001 |